Back
Results - Announcements
Kwality Pharmaceuticals Ltd consolidated sales up 3.34% on year in Q2FY2026
10-Aug-2026, 02:43
Kwality Pharmaceuticals Ltd share price softened by 1.64% to Rs 2609.05. The Company's net profit inched up 1.22% to Rs 25.62 crore, while revenue from operations slightly gained 3.34% to Rs 162.35 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.54 lakh crore, gaining 5.14%. It has marginally improved by 0.74% over last one week and climbed by 13.39% in last one month while the market capitalization of Kwality Pharmaceuticals Ltd has improved by 2.06% and 55.70% in the same period respectively. Profit before tax (PBT) of Kwality Pharmaceuticals Ltd stood at Rs 33.99 crore in Q2 FY26, jumping 99.59% year-on-year, and rising 7.33% quarter-on-quarter. EBITDA came in at Rs 40 crore, expanding by 69.78% YoY and easing 7.14% sequentially. Total expenses grew marginally by 2.19% to Rs 126.33 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 85.34 crore, inching up 7.10% YoY, while employee benefits expense was at Rs 14.74 crore, ticking higher by 3.66% YoY. For the TTM ended FY26, revenue from operations jumped by 20.52% to Rs 370.2 crore, while net profit soared by 68.50% to Rs 39.8 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 6221% to Rs 78.47 crore, and PBT witnessed a strong rise of 74.08% to Rs 54.14 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 52.72 crore in FY26, as against Rs 42.98 crore in FY25. Kwality Pharmaceuticals Ltd surged by 137.66% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.63% during the same period.
Kwality Pharmaceuticals Ltd share price softened by 1.64% to Rs 2609.05. The Company's net profit inched up 1.22% to Rs 25.62 crore, while revenue from operations slightly gained 3.34% to Rs 162.35 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.54 lakh crore, gaining 5.14%. It has marginally improved by 0.74% over last one week and climbed by 13.39% in last one month while the market capitalization of Kwality Pharmaceuticals Ltd has improved by 2.06% and 55.70% in the same period respectively. Profit before tax (PBT) of Kwality Pharmaceuticals Ltd stood at Rs 33.99 crore in Q2 FY26, jumping 99.59% year-on-year, and rising 7.33% quarter-on-quarter. EBITDA came in at Rs 40 crore, expanding by 69.78% YoY and easing 7.14% sequentially. Total expenses grew marginally by 2.19% to Rs 126.33 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 85.34 crore, inching up 7.10% YoY, while employee benefits expense was at Rs 14.74 crore, ticking higher by 3.66% YoY. For the TTM ended FY26, revenue from operations jumped by 20.52% to Rs 370.2 crore, while net profit soared by 68.50% to Rs 39.8 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 6221% to Rs 78.47 crore, and PBT witnessed a strong rise of 74.08% to Rs 54.14 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 52.72 crore in FY26, as against Rs 42.98 crore in FY25. Kwality Pharmaceuticals Ltd surged by 137.66% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.63% during the same period.